[artículo] 
inPsychiatric Clinics of North America > Año 2009 - Vol.32 No. 4 (Diciembre) . - pp. 775-794

Título :	Management of schizophrenia with obesity, metabolic, and endocrinological disorders
Tipo de documento:	texto impreso
Autores:	Palmiero Monteleone, Autor ; Vassilis Martiadis, Autor ; Mario Maj, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 775-794
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Esquizofrenia, Obesidad, Diabetes, Síndrome metabólico, Hiperprolactinemia
Resumen:	People with schizophrenia have an increased prevalence of overweight/obesity, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome, which increases the risk for cardiovascular diseases and mortality. Part of this increased risk is attributable to the use of antipsychotic medications, especially second-generation antipsychotics.
Link:	./index.php?lvl=notice_display&id=24443

[artículo] Management of schizophrenia with obesity, metabolic, and endocrinological disorders [texto impreso] / Palmiero Monteleone, Autor ; Vassilis Martiadis, Autor ; Mario Maj, Autor . - 2020 . - pp. 775-794.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2009 - Vol.32 No. 4 (Diciembre) . - pp. 775-794

Palabras clave:	Esquizofrenia, Obesidad, Diabetes, Síndrome metabólico, Hiperprolactinemia
Resumen:	People with schizophrenia have an increased prevalence of overweight/obesity, type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome, which increases the risk for cardiovascular diseases and mortality. Part of this increased risk is attributable to the use of antipsychotic medications, especially second-generation antipsychotics.
Link:	./index.php?lvl=notice_display&id=24443